LncRNAs: Potential Novel Prognostic and Diagnostic Biomarkers in Colorectal Cancer

被引:39
|
作者
Dastmalchi, Narges [1 ]
Safaralizadeh, Reza [1 ]
Nargesi, Mirsaed Miri [2 ]
机构
[1] Univ Tabriz, Fac Nat Sci, Dept Anim Biol, Tabriz, Iran
[2] Auckland Dist Hlth Board ADHB, Mol Virol Sect, Dept Virol & Immunol, LabPLUS, Auckland, New Zealand
关键词
Biomarkers; colorectal cancer (CRC); lncRNAs; diagnostic biomarkers in colorectal cancer; CRC; scaffolding factor; LONG NONCODING RNAS; THERAPEUTIC TARGET; CELL-PROLIFERATION; POOR-PROGNOSIS; PROTEIN HUR; METASTASIS; EXPRESSION; MALAT1; EMT; TRANSCRIPTION;
D O I
10.2174/0929867326666190227230024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Long non-coding RNAs (lncRNAs), a type of regulatory RNAs, play a key role in numerous cellular pathways. Ectopic expression of this group of non-coding RNAs has been specified to be involved in numerous diseases. Moreover, the role of lncRNAs in the initiation and development of cancers including colorectal cancer (CRC) has been acknowledged. Objective: In the present review, the role of lncRNAs as prognostic and diagnostic biomarkers in CRC as well as the molecular mechanisms of their contribution to development of CRC has been addressed. Results: The presented studies have indicated the ectopic expression of various lncRNAs in CRC. Some lncRNAs which were considered as tumor suppressors were downregulated in the colorectal cancerous tissues compared with healthy controls; however, some with oncogenic effects were upregulated. LncRNAs contribute to tumor development via various molecular mechanisms such as epigenetically controlling the expression of target genes, interacting with miRNAs as their sponge, etc. Conclusion: LncRNAs that have been recognized as prognostic biomarkers may pave the way for clinical management to offer adjuvant treatments for patients with CRC.
引用
收藏
页码:5067 / 5077
页数:11
相关论文
共 50 条
  • [31] Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review
    Moar, Kareena
    Pant, Anuja
    Saini, Vikas
    Pandey, Manisha
    Maurya, Pawan Kumar
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [32] Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers
    Exner, Ruth
    Pulverer, Walter
    Diem, Martina
    Spaller, Lisa
    Woltering, Laura
    Schreiber, Martin
    Wolf, Brigitte
    Sonntagbauer, Markus
    Schroeder, Fabian
    Stift, Judith
    Wrba, Fritz
    Bergmann, Michael
    Weinhaeusel, Andreas
    Egger, Gerda
    BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 1035 - 1045
  • [33] Potential of DNA methylation in rectal cancer as diagnostic and prognostic biomarkers
    Ruth Exner
    Walter Pulverer
    Martina Diem
    Lisa Spaller
    Laura Woltering
    Martin Schreiber
    Brigitte Wolf
    Markus Sonntagbauer
    Fabian Schröder
    Judith Stift
    Fritz Wrba
    Michael Bergmann
    Andreas Weinhäusel
    Gerda Egger
    British Journal of Cancer, 2015, 113 : 1035 - 1045
  • [34] Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation
    Meiyu Dai
    Xiaoli Chen
    Shanying Mo
    Jinwan Li
    Zhizhuo Huang
    Shifeng Huang
    Junyi Xu
    Baoyu He
    Yan Zou
    Jingfan Chen
    Shengming Dai
    Scientific Reports, 7
  • [35] Meta-signature LncRNAs serve as novel biomarkers for colorectal cancer: integrated bioinformatics analysis, experimental validation and diagnostic evaluation
    Dai, Meiyu
    Chen, Xiaoli
    Mo, Shanying
    Li, Jinwan
    Huang, Zhizhuo
    Huang, Shifeng
    Xu, Junyi
    He, Baoyu
    Zou, Yan
    Chen, Jingfan
    Dai, Shengming
    SCIENTIFIC REPORTS, 2017, 7
  • [36] Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis
    Niu, Chao
    Li, Xiaogang
    Luo, Xian Lei
    Wan, Hongwei
    Jin, Wendi
    Zhang, Zhiping
    Zhang, Wanfu
    Li, Bo
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (01): : 61 - +
  • [37] PRELIMINARY RESULTS OF lncRNAs AS BIOMARKERS FOR COLORECTAL CANCER DIAGNOSIS
    Fernandez Hevia, M.
    Fernandez Martinez, D.
    Cobzariu, M. A.
    Garcia Santos, G.
    Diaz Vico, T.
    Miranda Castro, R.
    Lobo Castanon, M. J.
    Garcia Florez, L. J.
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [38] Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer
    Liu, Yingting
    Chen, Junjun
    Li, An
    Wu, Yue
    Ge, Junwei
    Yuan, Maoling
    Xu, Bin
    Zheng, Xiao
    Chen, Lujun
    Jiang, Jingting
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [39] Diagnostic, prognostic, and predictive biomarkers in gastric cancer: from conventional to novel biomarkers
    Khalili-Tanha, Ghazaleh
    Khalili-Tanha, Nima
    Rouzbahani, Arian Karimi
    Mahdieh, Ramisa
    Jasemi, Kimia
    Ghaderi, Rosa
    Leylakoohi, Fatemeh Khojasteh
    Ghorbani, Elnaz
    Khazaei, Majid
    Hassanian, Seyed Mahdi
    Gataa, Ibrahim Saeed
    Ferns, Gordon
    Nazari, Elham
    Avan, Amir
    TRANSLATIONAL RESEARCH, 2024, 274 : 35 - 48
  • [40] Targeted metabolomics reveals novel diagnostic biomarkers for colorectal cancer
    Hu, Zuojian
    Shen, Fenglin
    Liu, Yang
    Zhong, Ziqing
    Chen, Yongling
    Xia, Zhiyuan
    Mo, Cuiju
    Yu, Hongxiu
    MOLECULAR ONCOLOGY, 2025,